Advertisement

Neuropsychiatric performance in patients with cirrhosis: Who is “normal”?

Published:December 03, 2016DOI:https://doi.org/10.1016/j.jhep.2016.11.021

      Summary

      In patients with cirrhosis a normal neuropsychiatric performance has been traditionally defined by the absence of any degree of hepatic encephalopathy and/or the absence of psychometric or neurophysiological abnormalities, compared with data from the healthy population. As the understanding and management of end-stage liver disease continues to change, it is our impression that the concept of normal neuropsychiatric performance also needs updating. This review explores novel and more pragmatic interpretations of neuropsychiatric “normality” compared with top personal performance, in terms of risk of overt hepatic encephalopathy or brain failure and in relation with events such as liver transplantation, decompensation, acute-on-chronic liver failure and transjugular intrahepatic portosystemic shunt placement.

      Keywords

      Linked Article

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Hepatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Parsons-Smith B.G.
        • Summerskill W.H.
        • Dawson A.M.
        • Sherlock S.
        The electroencephalograph in liver disease.
        Lancet. 1957; 273: 867-871
        • Rikkers L.
        • Jenko P.
        • Rudman D.
        • Freides D.
        Subclinical hepatic encephalopathy: detection, prevalence, and relationship to nitrogen metabolism.
        Gastroenterology. 1978; 75: 462-469
        • Gitlin N.
        • Lewis D.C.
        • Hinkley L.
        The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis.
        J Hepatol. 1986; 3: 75-82
        • Van der Rijt C.
        • Schalm S.W.
        Quantitative EEG analysis and survival in liver disease.
        Electroencephalogr Clin Neurophysiol. 1985; 61: 502-504
        • Sotil E.U.
        • Gottstein J.
        • Ayala E.
        • Randolph C.
        • Blei A.T.
        Impact of preoperative overt hepatic encephalopathy on neurocognitive function after liver transplantation.
        Liver Transpl. 2009; 15: 184-192
        • Bajaj J.S.
        • Schubert C.M.
        • Heuman D.M.
        • Wade J.B.
        • Gibson D.P.
        • Topaz A.
        • et al.
        Persistence of cognitive impairment after resolution of overt hepatic encephalopathy.
        Gastroenterology. 2010; 138: 2332-2340
        • Montagnese S.
        • Schiff S.
        • Amodio P.
        Quick diagnosis of hepatic encephalopathy: fact or fiction?.
        Hepatology. 2015; 61: 405-406
        • Groeneweg M.
        • Quero J.C.
        • De Bruijn I.
        • Hartmann I.J.
        • Essink-bot M.L.
        • Hop W.C.
        • et al.
        Subclinical hepatic encephalopathy impairs daily functioning.
        Hepatology. 1998; 28: 45-49
        • Bajaj J.S.
        • Riggio O.
        • Allampati S.
        • Prakash R.
        • Gioia S.
        • Onori E.
        • et al.
        Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study.
        Clin Gastroenterol Hepatol. 2013; 11: 1511-1516
        • Montagnese S.
        • Amato E.
        • Schiff S.
        • Facchini S.
        • Angeli P.
        • Gatta A.
        • et al.
        A patients' and caregivers' perspective on hepatic encephalopathy.
        Metab Brain Dis. 2012; 27: 567-572
        • Amodio P.
        • Montagnese S.
        • Merkel C.
        Attention: Minimal hepatic encephalopathy and road accidents.
        Hepatology. 2012; 55: 985-987
        • Kircheis G.
        • Knoche A.
        • Hilger N.
        • Manhart F.
        • Schnitzler A.
        • Schulze H.
        • et al.
        Hepatic encephalopathy and fitness to drive.
        Gastroenterology. 2009; 137: 1706-1715
        • Kircheis G.
        • Bode J.G.
        • Hilger N.
        • Kramer T.
        • Schnitzler A.
        • Haussinger D.
        Diagnostic and prognostic values of critical flicker frequency determination as new diagnostic tool for objective HE evaluation in patients undergoing TIPS implantation.
        Eur J Gastroenterol Hepatol. 2009; 21: 1383-1394
        • Berlioux P.
        • Robic M.A.
        • Poirson H.
        • Metivier S.
        • Otal P.
        • Barret C.
        • et al.
        Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
        Hepatology. 2014; 59: 622-629
        • Riggio O.
        • Nardelli S.
        • Moscucci F.
        • Pasquale C.
        • Ridola L.
        • Merli M.
        Hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
        Clin Liver Dis. 2012; 16: 133-146
        • Riggio O.
        • Angeloni S.
        • Salvatori F.M.
        • De S.A.
        • Cerini F.
        • Farcomeni A.
        • et al.
        Incidence, natural history, and risk factors of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stent grafts.
        Am J Gastroenterol. 2008; 103: 2738-2746
        • Salerno F.
        • Camma C.
        • Enea M.
        • Rossle M.
        • Wong F.
        Transjugular intrahepatic portosystemic shunt for refractory ascites: a meta-analysis of individual patient data.
        Gastroenterology. 2007; 133: 825-834
        • Bajaj J.S.
        • Cordoba J.
        • Mullen K.D.
        • Amodio P.
        • Shawcross D.L.
        • Butterworth R.F.
        • et al.
        Review article: the design of clinical trials in hepatic encephalopathy–an International Society for Hepatic Encephalopathy and Nitrogen Metabolism (ISHEN) consensus statement.
        Aliment Pharmacol Ther. 2011; 33: 739-747
        • Vilstrup H.
        • Amodio P.
        • Bajaj J.
        • Cordoba J.
        • Ferenci P.
        • Mullen K.D.
        • et al.
        Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.
        Hepatology. 2014; 60: 715-735
        • Conn H.O.
        • Leevy C.M.
        • Vlahcevic Z.R.
        • Rodgers J.B.
        • Maddrey W.C.
        • Seeff L.
        • et al.
        Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.
        Gastroenterology. 1977; 72: 573-583
        • Kircheis G.
        • Fleig W.E.
        • Görtelmeyer R.
        • Grafe S.
        • Häussinger D.
        Assessment of low-grade hepatic encephalopathy: a critical analysis.
        J Hepatol. 2007; 47: 642-650
        • Morgan M.Y.
        • Amodio P.
        • Cook N.A.
        • Jackson C.D.
        • Kircheis G.
        • Lauridsen M.M.
        • et al.
        Qualifying and quantifying minimal hepatic encephalopathy.
        Metab Brain Dis. 2016; 31: 1217-1229
        • Weiner M.F.
        Dementia as a psychobiological process.
        in: Weiner M.F. The Dementias diagnosis management and research. 2nd ed. America Psychiatric Press, Washington1996: 43-63
        • Inouye S.K.
        • Westendorp R.G.
        • Saczynski J.S.
        Delirium in elderly people.
        Lancet. 2014; 383: 911-922
        • Hindle J.V.
        • Hurt C.S.
        • Burn D.J.
        • Brown R.G.
        • Samuel M.
        • Wilson K.C.
        • et al.
        The effects of cognitive reserve and lifestyle on cognition and dementia in Parkinson's disease–a longitudinal cohort study.
        Int J Geriatr Psychiatry. 2016; 31: 13-23
        • Cordoba J.
        • Ventura-Cots M.
        • Simon-Talero M.
        • Amoros A.
        • Pavesi M.
        • Vilstrup H.
        • et al.
        Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF).
        J Hepatol. 2014; 60: 275-281
        • Morgan M.Y.
        • Alonso M.
        • Stanger L.C.
        Lactitol and lactulose for the treatment of subclinical hepatic encephalopathy in cirrhotic patients. A randomised, cross-over study.
        J Hepatol. 1989; 8: 208-217
        • Srivastava A.
        • Mehta R.
        • Rothke S.P.
        • Rademaker A.W.
        • Blei A.T.
        Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance.
        J Hepatol. 1994; 21: 1023-1028
        • Amodio P.
        • Quero J.C.
        • Del P.F.
        • Gatta A.
        • Schalm S.W.
        Diagnostic tools for the detection of subclinical hepatic encephalopathy: comparison of standard and computerized psychometric tests with spectral-EEG.
        Metab Brain Dis. 1996; 11: 315-327
        • Quero J.C.
        • Hartmann I.J.
        • Meulstee J.
        • Hop W.C.
        • Schalm S.W.
        The diagnosis of subclinical hepatic encephalopathy in patients with cirrhosis using neuropsychological tests and automated electroencephalogram analysis.
        Hepatology. 1996; 24: 556-560
        • Watanabe A.
        • Sakai T.
        • Sato S.
        • Imai F.
        • Ohto M.
        • Arakawa Y.
        • et al.
        Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy.
        Hepatology. 1997; 26: 1410-1414
        • Kircheis G.
        • Nilius R.
        • Held C.
        • Berndt H.
        • Buchner M.
        • Gortelmeyer R.
        • et al.
        Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
        Hepatology. 1997; 25: 1351-1360
        • Nolte W.
        • Wiltfang J.
        • Schindler C.
        • Munke H.
        • Unterberg K.
        • Zumhasch U.
        • et al.
        Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
        Hepatology. 1998; 28: 1215-1225
        • Amodio P.
        • Marchetti P.
        • Del Piccolo F.
        • Rizzo C.
        • Iemmolo R.M.
        • Caregaro L.
        • et al.
        Study on the Sternberg paradigm in cirrhotic patients without overt hepatic encephalopathy.
        Metab Brain Dis. 1998; 13: 159-172
        • Stauch S.
        • Kircheis G.
        • Adler G.
        • Beckh K.
        • Ditschuneit H.
        • Gortelmeyer R.
        • et al.
        Oral L-ornithine-L-aspartate therapy of chronic hepatic encephalopathy: results of a placebo-controlled double-blind study.
        J Hepatol. 1998; 28: 856-864
        • Yang S.S.
        • Wu C.H.
        • Chiang T.R.
        • Chen D.S.
        Somatosensory evoked potentials in subclinical portosystemic encephalopathy: a comparison with psychometric tests.
        Hepatology. 1998; 27: 357-361
        • Groeneweg M.
        • Moerland W.
        • Quero J.C.
        • Hop W.C.
        • Krabbe P.F.
        • Schalm S.W.
        Screening of subclinical hepatic encephalopathy.
        J Hepatol. 2000; 32: 748-753
        • Hartmann I.J.
        • Groeneweg M.
        • Quero J.C.
        • Beijeman S.J.
        • de Man R.A.
        • Hop W.C.
        • et al.
        The prognostic significance of subclinical hepatic encephalopathy.
        Am J Gastroenterol. 2000; 95: 2029-2034
        • Dhiman R.K.
        • Sawhney M.S.
        • Chawla Y.K.
        • Das G.
        • Ram S.
        • Dilawari J.B.
        Efficacy of lactulose in cirrhotic patients with subclinical hepatic encephalopathy.
        Dig Dis Sci. 2000; 45: 1549-1552
        • Romero-Gomez M.
        • Boza F.
        • Garcia-Valdecasas M.S.
        • Garcia E.
        • Aguilar-Reina J.
        Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.
        Am J Gastroenterol. 2001; 96: 2718-2723
        • Das A.
        • Dhiman R.K.
        • Saraswat V.A.
        • Verma M.
        • Naik S.R.
        Prevalence and natural history of subclinical hepatic encephalopathy in cirrhosis.
        J Gastroenterol Hepatol. 2001; 16: 531-535
        • Saxena N.
        • Bhatia M.
        • Joshi Y.K.
        • Garg P.K.
        • Tandon R.K.
        Auditory P300 event-related potentials and number connection test for evaluation of subclinical hepatic encephalopathy in patients with cirrhosis of the liver: a follow-up study.
        J Gastroenterol Hepatol. 2001; 16: 322-327
        • Kircheis G.
        • Wettstein M.
        • Timmermann L.
        • Schnitzler A.
        • Haussinger D.
        Critical flicker frequency for quantification of low-grade hepatic encephalopathy.
        Hepatology. 2002; 35: 357-366
        • Arguedas M.R.
        • DeLawrence T.G.
        • McGuire B.M.
        Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis.
        Dig Dis Sci. 2003; 48: 1622-1626
        • Li Y.Y.
        • Nie Y.Q.
        • Sha W.H.
        • Zeng Z.
        • Yang F.Y.
        • Ping L.
        • et al.
        Prevalence of subclinical hepatic encephalopathy in cirrhotic patients in China.
        World J Gastroenterol. 2004; 10: 2397-2401
        • Montagnese S.
        • Jackson C.
        • Morgan M.Y.
        Spatio-temporal decomposition of the electroencephalogram in patients with cirrhosis.
        J Hepatol. 2007; 46: 447-458
        • Bajaj J.S.
        • Saeian K.
        • Schubert C.M.
        • Hafeezullah M.
        • Franco J.
        • Varma R.R.
        • et al.
        Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test.
        Hepatology. 2009; 50: 1175-1183
        • Li S.W.
        • Wang K.
        • Yu Y.Q.
        • Wang H.B.
        • Li Y.H.
        • Xu J.M.
        Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China.
        World J Gastroenterol. 2013; 19: 8745-8751
        • Tsushima M.
        • Tsushima W.
        • Tsushima V.
        • Lim N.
        • Madrigal E.
        • Jackson C.
        • et al.
        Use of ImPACT to diagnose minimal hepatic encephalopathy: an accurate, practical, user-friendly internet-based neuropsychological test battery.
        Dig Dis Sci. 2013; 58: 2673-2681
        • Bisiacchi P.
        • Cona G.
        • Tarantino V.
        • Schiff S.
        • Montagnese S.
        • Amodio P.
        • et al.
        Assessing inter- and intra-individual cognitive variability in patients at risk for cognitive impairment: the case of minimal hepatic encephalopathy.
        Metab Brain Dis. 2014; 29: 945-953
        • Patidar K.R.
        • Thacker L.R.
        • Wade J.B.
        • Sterling R.K.
        • Sanyal A.J.
        • Siddiqui M.S.
        • et al.
        Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
        Am J Gastroenterol. 2014; 109: 1757-1763
        • Nabi E.
        • Thacker L.R.
        • Wade J.B.
        • Sterling R.K.
        • Stravitz R.T.
        • Fuchs M.
        • et al.
        Diagnosis of covert hepatic encephalopathy without specialized tests.
        Clin Gastroenterol Hepatol. 2014; 12: 1384-1389
        • Kircheis G.
        • Hilger N.
        • Haussinger D.
        Value of critical flicker frequency and psychometric hepatic encephalopathy score in diagnosis of low-grade hepatic encephalopathy.
        Gastroenterology. 2014; 146: 961-969
        • Mina A.
        • Moran S.
        • Ortiz-Olvera N.
        • Mera R.
        • Uribe M.
        Prevalence of minimal hepatic encephalopathy and quality of life in patients with decompensated cirrhosis.
        Hepatol Res. 2014; 44: E92-E99
        • Patel A.V.
        • Wade J.B.
        • Thacker L.R.
        • Sterling R.K.
        • Siddiqui M.S.
        • Stravitz R.T.
        • et al.
        Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
        Clin Gastroenterol Hepatol. 2015; 13: 987-991
        • Ampuero J.
        • Simon M.
        • Montoliu C.
        • Jover R.
        • Serra M.A.
        • Cordoba J.
        • et al.
        Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
        Gastroenterology. 2015; 149: 1483-1489
        • Pratap M.V.
        • Benjamin J.
        • Bhushan S.M.
        • Mani K.
        • Garg S.K.
        • Saraya A.
        • et al.
        Effect of probiotic VSL#3 in the treatment of minimal hepatic encephalopathy: A non-inferiority randomized controlled trial.
        Hepatol Res. 2015; 45: 880-889
        • Montagnese S.
        • Balistreri E.
        • Schiff S.
        • De Rui M.
        • Angeli P.
        • Zanus G.
        • et al.
        Covert hepatic encephalopathy: agreement and predictive validity of different indices.
        World J Gastroenterol. 2014; 20: 15756-15762
        • Thomsen K.L.
        • Macnaughtan J.
        • Tritto G.
        • Mookerjee R.P.
        • Jalan R.
        Clinical and pathophysiological characteristics of cirrhotic patients with grade 1 and minimal hepatic encephalopathy.
        PLoS One. 2016; 11e0146076
        • Sidhu S.S.
        • Goyal O.
        • Parker R.A.
        • Kishore H.
        • Sood A.
        Rifaximin vs. lactulose in treatment of minimal hepatic encephalopathy.
        Liver Int. 2016; 36: 378-385
        • Singh J.
        • Sharma B.C.
        • Maharshi S.
        • Puri V.
        • Srivastava S.
        Spectral electroencephalogram in liver cirrhosis with minimal hepatic encephalopathy before and after lactulose therapy.
        J Gastroenterol Hepatol. 2016; 31: 1203-1209
        • Weissenborn K.
        • Giewekemeyer K.
        • Heidenreich S.
        • Bokemeyer M.
        • Berding G.
        • Ahl B.
        Attention, memory, and cognitive function in hepatic encephalopathy.
        Metab Brain Dis. 2005; 20: 359-367
        • Romero-Gomez M.
        • Cordoba J.
        • Jover R.
        • del Olmo J.A.
        • Ramirez M.
        • Rey R.
        • et al.
        Value of the critical flicker frequency in patients with minimal hepatic encephalopathy.
        Hepatology. 2007; 45: 879-885
        • Schiff S.
        • Valenti P.
        • Andrea P.
        • Lot M.
        • Bisiacchi P.
        • Gatta A.
        • et al.
        The effect of aging on auditory components of event-related brain potentials.
        Clin Neurophysiol. 2008; 119: 1795-1802
        • Weissenborn K.
        • Tillmann H.L.
        HCV encephalopathy – an artefact due to medical care?.
        J Viral Hepat. 2016; 23: 580-583
        • Schiff S.
        • Vallesi A.
        • Mapelli D.
        • Orsato R.
        • Pellegrini A.
        • Umilta C.
        • et al.
        Impairment of response inhibition precedes motor alteration in the early stage of liver cirrhosis: a behavioral and electrophysiological study.
        Metab Brain Dis. 2005; 20: 381-392
        • Amodio P.
        • Cordoba J.
        Smart applications for assessing minimal hepatic encephalopathy: novelty from the app revolution.
        Hepatology. 2013; 58: 844-846
        • Montagnese S.
        • Schiff S.
        • Turco M.
        • Bonato C.A.
        • Ridola L.
        • Gatta A.
        • et al.
        Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy.
        Dig Liver Dis. 2012; 44: 957-960
        • Montagnese S.
        • Schiff S.
        • De Rui M.
        • Crossey M.M.
        • Amodio P.
        • Taylor-Robinson S.D.
        Neuropsychological tools in hepatology: a survival guide for the clinician.
        J Viral Hepat. 2012; 19: 307-315
        • Bajaj J.S.
        • Etemadian A.
        • Hafeezullah M.
        • Saeian K.
        Testing for minimal hepatic encephalopathy in the United States: An AASLD survey.
        Hepatology. 2007; 45: 833-834
        • Weissenborn K.
        • Ennen J.C.
        • Schomerus H.
        • Ruckert N.
        • Hecker H.
        Neuropsychological characterization of hepatic encephalopathy.
        J Hepatol. 2001; 34: 768-773
        • Seo Y.S.
        • Yim S.Y.
        • Jung J.Y.
        • Kim C.H.
        • Kim J.D.
        • Keum B.
        • et al.
        Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis.
        J Gastroenterol Hepatol. 2012; 27: 1695-1704
        • Romero G.M.
        • Cordoba J.
        • Jover R.
        • del Olmo J.
        • Fernandez A.
        • Flavia M.
        • et al.
        Normality tables in the Spanish population for psychometric tests used in the diagnosis of minimal hepatic encephalopathy.
        Med Clin (Barc). 2006; 127: 246-249
        • Amodio P.
        • Campagna F.
        • Olianas S.
        • Iannizzi P.
        • Mapelli D.
        • Penzo M.
        • et al.
        Detection of minimal hepatic encephalopathy: normalization and optimization of the Psychometric Hepatic Encephalopathy Score. A neuropsychological and quantified EEG study.
        J Hepatol. 2008; 49: 346-353
        • Elsass P.
        • Christensen S.E.
        • Jorgensen F.
        • Mortensen E.L.
        • Vilstrup H.
        Number connection test and continuous reaction times in assessment of organic and metabolic encephalopathy: a comparative study.
        Acta Pharmacol Toxicol (Copenh). 1984; 54: 115-119
        • Lauridsen M.M.
        • Thiele M.
        • Kimer N.
        • Vilstrup H.
        The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy.
        Metab Brain Dis. 2013; 28: 231-234
        • Bajaj J.S.
        • Saeian K.
        • Verber M.D.
        • Hischke D.
        • Hoffmann R.G.
        • Franco J.
        • et al.
        Inhibitory control test is a simple method to diagnose minimal hepatic encephalopathy and predict development of overt hepatic encephalopathy.
        Am J Gastroenterol. 2007; 102: 754-760
        • Amodio P.
        • Schiff S.
        • Del Piccolo F.
        • Mapelli D.
        • Gatta A.
        • Umilta C.
        Attention dysfunction in cirrhotic patients: an inquiry on the role of executive control, attention orienting and focusing.
        Metab Brain Dis. 2005; 20: 115-127
        • Amodio P.
        • Del Piccolo F.
        • Petteno E.
        • Mapelli D.
        • Angeli P.
        • Iemmolo R.
        • et al.
        Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients.
        J Hepatol. 2001; 35: 37-45
        • Bajaj J.S.
        • Thacker L.R.
        • Heuman D.M.
        • Fuchs M.
        • Sterling R.K.
        • Sanyal A.J.
        • et al.
        The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
        Hepatology. 2013; 58: 1122-1132
        • Schiff S.
        • Casa M.
        • Di Caro V.
        • Aprile D.
        • Spinelli G.
        • De Rui M.
        • et al.
        A low-cost, user-friendly electroencephalographic recording system for the assessment of hepatic encephalopathy.
        Hepatology. 2016; 63: 1651-1659
        • Montagnese S.
        • Cona G.
        • Schiff S.
        • Maresio G.
        • Gatta A.
        • Merkel C.
        • et al.
        The hunter and the pianist: two hepatic encephalopathy tales.
        J Clin Gastroenterol. 2011; 45: 563-566
        • Nucci M.
        • Mapelli D.
        • Mondini S.
        Cognitive Reserve Index questionnaire (CRIq): a new instrument for measuring cognitive reserve.
        Aging Clin Exp Res. 2012; 24: 218-226
        • Bajaj J.S.
        • Wade J.B.
        • Gibson D.P.
        • Heuman D.M.
        • Thacker L.R.
        • Sterling R.K.
        • et al.
        The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.
        Am J Gastroenterol. 2011; 106: 1646-1653
        • Katz S.
        • Ford A.B.
        • Moskowitz R.W.
        • Jackson B.A.
        • Jaffe M.W.
        Studies of illness in the aged. The index of the ADL: a standardized measure of biological and psychosocial function.
        JAMA. 1963; 185: 914-919
        • Marchesini G.
        • Bianchi G.
        • Amodio P.
        • Salerno F.
        • Merli M.
        • Panella C.
        • et al.
        Factors associated with poor health-related quality of life of patients with cirrhosis.
        Gastroenterology. 2001; 120: 170-178
        • Jackson C.D.
        • Gram M.
        • Halliday E.
        • Olesen S.S.
        • Sandberg T.H.
        • Drewes A.M.
        • et al.
        New spectral thresholds improve the utility of the electroencephalogram for the diagnosis of hepatic encephalopathy.
        Clin Neurophysiol. 2016; 127: 2933-2941
        • Romero-Gomez M.
        • Montagnese S.
        • Jalan R.
        Hepatic encephalopathy in patients with acute decompensation of cirrhosis and acute-on-chronic liver failure.
        J Hepatol. 2015; 62: 437-447
        • Douglass A.
        • Al M.H.
        • Record C.
        Amino acid challenge in patients with cirrhosis: a model for the assessment of treatments for hepatic encephalopathy.
        J Hepatol. 2001; 34: 658-664
        • Romero-Gomez M.
        • Grande L.
        • Camacho I.
        Prognostic value of altered oral glutamine challenge in patients with minimal hepatic encephalopathy.
        Hepatology. 2004; 39: 939-943
        • Bersagliere A.
        • Raduazzo I.D.
        • Schiff S.
        • Gatta A.
        • Merkel C.
        • Amodio P.
        • et al.
        Ammonia-related changes in cerebral electrogenesis in healthy subjects and patients with cirrhosis.
        Clin Neurophysiol. 2013; 124: 492-496